Transaction DateRecipientSharesTypePriceValue
1st September 2020Charles J Casamento3,000Open or private sale$34.74$104,206.80
18th August 2020Charles J Casamento2,189Payment by withholding$39.03$85,436.67
18th August 2020Charles J Casamento26,362Exercise of derivative$3.24$85,412.88
3rd August 2020Charles J Casamento3,000Open or private sale$35.74$107,213.40
1st July 2020Charles J Casamento3,000Open or private sale$43.89$131,677.20
19th March 2020Charles J Casamento9,000Bona fide gift$0.00
19th March 2020Charles J Casamento9,000Bona fide gift$0.00
17th March 2020Charles J Casamento21,484Bona fide gift$0.00
17th March 2020Charles J Casamento21,484Bona fide gift$0.00
11th March 2020Charles J Casamento14,584Grant/award etc.$0.60$8,750.40
Eton Pharmaceuticals
Eton Pharmaceuticals logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.


Eton Pharmaceuticals, Inc. engages in the development and commercialization of prescription drug products. Its portfolio consists of injectable, oral liquid, ophthalmic products pipelines.


Ticker: ETON
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1710340
Employees: 17
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals